Stockreport

Capricor Therapeutics partners with Nippon Shinyaku for European commercialization of Deramiocel [Seeking Alpha]

Capricor Therapeutics, Inc.  (CAPR) 
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors
PDF commercialization and distribution in Europe of Capricor's lead asset, deramiocel, for the treatment of Duchenne muscular dystrophy. Nippon Shinyaku has agreed to purc [Read more]